Becton, Dickinson and Company (BDX)
(Delayed Data from NYSE)
$237.84 USD
+0.54 (0.23%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $237.77 -0.07 (-0.03%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth F Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
BDX 237.84 +0.54(0.23%)
Will BDX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for BDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BDX
Sustained Product Demand Likely to Aid BD's (BDX) Q3 Earnings
Countdown to Becton Dickinson (BDX) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
BDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio Now
Veeva Systems' (VEEV) Vault EDC to Boost Vita Global's Workflow
Reasons to Add The Cooper Companies (COO) to Your Portfolio Now
Other News for BDX
Key Takeaways From Becton Dickinson Analyst Ratings
Becton Dickinson price target raised by $10 at Stifel, here's why
Becton, Dickinson (BDX) Shares Cross Above 200 DMA
Becton Dickinson, Quest Diagnostics enter collaboration agreement
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases